We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · September 02, 2020

T4 and TSH Index for Predicting Development of Ipilimumab-Induced Hypophysitis

Journal of Endocrinological Investigation


Additional Info

Journal of Endocrinological Investigation
Predicting Development of Ipilimumab-Induced Hypophysitis: Utility of T4 and TSH Index but Not TSH
J. Endocrinol. Invest. 2020 May 24;[EPub Ahead of Print], MS Siddiqui, ZM Lai, L Spain, V Greener, S Turajlic, J Larkin, DL Morganstein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading